EMILY BURKMAN: Open Payments
NPI 1447756465 · KAILUA KONA, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,050 in 40 payments from 9 companies in 2025. Trend: 2023 $898 · 2024 $2,094 · 2025 $1,050
Food & beverage: $940Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $332 |
| Janssen Biotech, Inc. | 6 | $218 |
| Amgen Inc. | 5 | $183 |
| UCB, Inc. | 4 | $105 |
| Regeneron Healthcare Solutions, Inc. | 3 | $80 |
| Lilly USA, LLC | 2 | $57 |
| Organon LLC | 1 | $30 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| Galderma Laboratories, L.P. | 1 | $15 |
Products named: TREMFYA, SKYRIZI, OTEZLA, Bimzelx, BOTOX, DUPIXENT, RINVOQ, VTAMA.
Industry payments across HI — which companies pay providers there.
